Novel antibiotics for the treatment ofStaphylococcus aureus

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

(2010) Y.-T. Huang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multicenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections

(2009) D. Krievins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibitory and Bactericidal Activities of Daptomycin, Vancomycin, and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Isolates Collected from 1985 to 2007

(2009) M. M. Traczewski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates

(2009) D. J. Biedenbach et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Management of methicillin-resistant Staphylococcus aureus infections

(2009) J. Garau et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)

(2009) Douglas J. Biedenbach et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Ceftaroline

(2009) George G. Zhanel et al.   DRUGS

Ceftaroline: a cephalosporin with expanded Gram-positive activity

(2009) Zeina A Kanafani et al.   Future Microbiology

Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

(2009) E. De Cock et al.   INFECTION

Dalbavancin: A new lipoglycopeptide antibiotic

(2008) J. Bailey et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens

(2008) L. Lawrence et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

(2008) D. C. Draghi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of Ceftobiprole, Linezolid, Vancomycin, and Daptomycin against Community-Associated and Hospital-Associated Methicillin-Resistant Staphylococcus aureus

(2008) S. N. Leonard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methicillin-Resistant and -Susceptible Staphylococcus aureus Strains of Clonal Lineages ST398 and ST9 from Swine Carry the Multidrug Resistance Gene cfr

(2008) C. Kehrenberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

(2008) R. E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Pathogenesis of Methicillin‐ResistantStaphylococcus aureusInfection

(2008) Rachel J. Gordon et al.   CLINICAL INFECTIOUS DISEASES

What's new and not so new on the antimicrobial horizon?

(2008) G.L. French   CLINICAL MICROBIOLOGY AND INFECTION

Bacteriophage lysins as effective antibacterials

(2008) Vincent A Fischetti   CURRENT OPINION IN MICROBIOLOGY

Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers

(2008) Ana C. Gales et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial activity of ceftobiprole, a novel anti–methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005–2006)

(2008) Thomas R. Fritsche et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

United States resistance surveillance results for linezolid (LEADER Program for 2007)

(2008) Ronald N. Jones et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Oritavancin: a potential weapon in the battle against serious Gram-positive pathogens

(2008) Jared Crandon et al.   Future Microbiology

Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens

(2008) Wolfgang Witte et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative

(2008) D. C. Draghi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

(2008) I. Florescu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit

(2008) S. Swoboda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and Etest

(2008) C. M. Pillar et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit∥

(2008) Joseph A. Ippolito et al.   JOURNAL OF MEDICINAL CHEMISTRY

The role of virulence determinants in community-associated MRSA pathogenesis

(2008) Binh An Diep et al.   TRENDS IN MICROBIOLOGY